Shuntaro Kodama
Director/Board Member at Junten Bio Co. Ltd.
Profile
Shuntaro Kodama is currently a Director at REGiMMUNE Corp., a Managing Director at DCI Partners KK, and a Director at Junten Bio Co. Ltd.
He previously held positions as a Director at Kidswell Bio Corp.
and Noile-Immune Biotech, Inc. Kodama received a graduate degree from the University of Tsukuba in 2012 and another graduate degree from Tokyo University of Science in 2005.
Shuntaro Kodama active positions
Companies | Position | Start |
---|---|---|
Junten Bio Co. Ltd.
Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Director/Board Member | - |
DCI Partners KK
DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Director/Board Member | 2014-05-19 |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Director/Board Member | 2019-11-30 |
Former positions of Shuntaro Kodama
Companies | Position | End |
---|---|---|
NOILE-IMMUNE BIOTECH INC. | Director/Board Member | - |
KIDSWELL BIO CORPORATION | Director/Board Member | - |
Training of Shuntaro Kodama
University of Tsukuba | Graduate Degree |
Tokyo University of Science | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NOILE-IMMUNE BIOTECH INC. | Health Technology |
KIDSWELL BIO CORPORATION | Health Technology |
Private companies | 3 |
---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
DCI Partners KK
DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Finance |
Junten Bio Co. Ltd.
Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Commercial Services |
- Stock Market
- Insiders
- Shuntaro Kodama